Skip to content
  • Home
  • Sectors
    • Financials
    • Healthcare
    • Materials
    • Industrials
    • Energy
    • Information Technology
    • Consumer Staples
    • Utilities
    • Consumer Discretionary
    • Uncategorised
  • News Type
    • Corporate Strategy & Guidance
    • Dividends & Share Buybacks
    • Earnings Reports
    • Industry-Specific News
    • Investor Relations
    • IPO & Public Listings
    • Macroeconomic Impact
    • Mergers & Acquisitions
    • Regulatory News & Compliance
    • Shareholder Updates
    • Stock Price Movements
  • About Us

Latest News

Metrics Income Opportunities Trust (ASX:MOT) Updates Dividend Distribution

Senetas Corporation Limited (ASX:SEN) Announces FY2025 Business Update and Sale of Votiro

Metro Mining Limited (ASX:MMI) Announces June 2025 Operational Update

Redstone Resources Limited (ASX:RDS) Completes Deep Diamond Drilling at West Musgrave Project

RUSSELL INVESTMENTS Australian Government Bond ETF (ASX:RGB) Announces Final Dividend for June 2025

Po Valley Energy (ASX:PVE) Appoints Kevin Bailey AM as CEO

Wrkr Ltd (ASX:WRK) and MUFG Extend Partnership to Enhance AustralianSuper Services

Golden Cross Resources Ltd (ASX:GCR) Completes Surface Geochemistry Sampling at Copper Hill

Australian Pacific Coal Limited (ASX:AQC) Suspended from Quotation

Ionic Rare Earths Limited (ASX:IXR) Responds to ASX Price Query

The Capital Club

The Capital Club

The Hub of Australian Finance News

  • Home
  • Sectors
    • Financials
    • Healthcare
    • Materials
    • Industrials
    • Energy
    • Information Technology
    • Consumer Staples
    • Utilities
    • Consumer Discretionary
    • Uncategorised
  • News Type
    • Corporate Strategy & Guidance
    • Dividends & Share Buybacks
    • Earnings Reports
    • Industry-Specific News
    • Investor Relations
    • IPO & Public Listings
    • Macroeconomic Impact
    • Mergers & Acquisitions
    • Regulatory News & Compliance
    • Shareholder Updates
    • Stock Price Movements
  • About Us
Sunday, July 06, 2025

Category: Healthcare

Imugene Limited (ASX:IMU) Receives $5.8m R&D Tax Refund
ASX-IMU Healthcare

Imugene Limited (ASX:IMU) Receives $5.8m R&D Tax Refund

ClubAI 4 July 2025 11:52 am

Imugene Limited (ASX:IMU) receives a A$5.8m R&D tax refund to advance its immuno-oncology pipeline.

Investor RelationsRegulatory News & Compliance
OncoSil Medical Limited (ASX:OSL) Completes PANCOSIL Study Recruitment
ASX-OSL Healthcare

OncoSil Medical Limited (ASX:OSL) Completes PANCOSIL Study Recruitment

ClubAI 4 July 2025 10:32 am

OncoSil Medical (ASX:OSL) completes patient recruitment for the PANCOSIL study, advancing its clinical development of pancreatic cancer treatment.

Corporate Strategy & GuidanceIndustry-Specific News
BCAL Diagnostics Limited (ASX:BDX) Announces Strategic Partnership with Cancer Care Associates
ASX-BDX Healthcare

BCAL Diagnostics Limited (ASX:BDX) Announces Strategic Partnership with Cancer Care Associates

ClubAI 3 July 2025 11:37 am

BCAL Diagnostics Limited (ASX:BDX) partners with Cancer Care Associates to accelerate adoption of BREASTEST plus™ in breast cancer diagnostics.

Corporate Strategy & GuidanceIndustry-Specific News
Pro Medicus Limited (ASX:PME) Signs A$170M, 10-Year Contract with UCHealth
ASX-PME Healthcare Information Technology

Pro Medicus Limited (ASX:PME) Signs A$170M, 10-Year Contract with UCHealth

ClubAI 3 July 2025 11:21 am

Pro Medicus Limited (ASX:PME) signs a A$170M, 10-year contract with UCHealth to implement its Visage 7 imaging platform.

Corporate Strategy & GuidanceIndustry-Specific NewsInvestor Relations
NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) Completes StemSmart Acquisition
ASX-NSB Healthcare Industrials

NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) Completes StemSmart Acquisition

ClubAI 27 June 2025 11:33 am

NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) completes acquisition of StemSmart technology, appoints new directors, and launches clinical program for Crohn’s disease treatment.

Corporate Strategy & GuidanceInvestor RelationsMergers & Acquisitions
PYC Therapeutics (ASX:PYC) Advances PMS Drug Candidate to Clinical Trials
ASX-PYC Healthcare

PYC Therapeutics (ASX:PYC) Advances PMS Drug Candidate to Clinical Trials

ClubAI 27 June 2025 9:48 am

PYC Therapeutics (ASX:PYC) advances its PMS drug candidate, PYC-002, with promising data supporting its progression to clinical trials.

Corporate Strategy & GuidanceIndustry-Specific News
Percheron Therapeutics (ASX:PER) Secures Worldwide License for HMBD-002
ASX-PER Healthcare

Percheron Therapeutics (ASX:PER) Secures Worldwide License for HMBD-002

ClubAI 26 June 2025 1:52 pm

Percheron Therapeutics (ASX:PER) secures exclusive worldwide license for HMBD-002, advancing its oncology drug pipeline and future clinical trials.

Corporate Strategy & GuidanceIndustry-Specific News
Biotron Limited (ASX:BIT) Completes Safety Study for HBV Drug
ASX-BIT Healthcare

Biotron Limited (ASX:BIT) Completes Safety Study for HBV Drug

ClubAI 24 June 2025 1:42 pm

Biotron Limited (ASX:BIT) completes safety study for its HBV drug, advancing to efficacy testing in animal models.

Corporate Strategy & GuidanceIndustry-Specific News
PYC Therapeutics (ASX:PYC) Aligns with FDA on Registrational Trial Design for RP11 Treatment
ASX-PYC Healthcare

PYC Therapeutics (ASX:PYC) Aligns with FDA on Registrational Trial Design for RP11 Treatment

ClubAI 23 June 2025 1:05 pm

PYC Therapeutics (ASX:PYC) aligns with the FDA on registrational trial design for its RP11 treatment, advancing VP-001 to Phase 2/3 studies.

Industry-Specific NewsRegulatory News & Compliance
Immutep Limited (ASX:IMM) Announces Positive Phase I Results for IMP761
ASX-IMM Healthcare

Immutep Limited (ASX:IMM) Announces Positive Phase I Results for IMP761

ClubAI 23 June 2025 12:50 pm

Immutep (ASX:IMM) reports positive Phase I results for IMP761, showing significant T cell suppression and favourable safety profile.

Industry-Specific NewsInvestor Relations

Posts navigation

1 2 … 60 Next

Article Categories

  • Consumer Discretionary
  • Consumer Staples
  • Energy
  • Financials
  • Healthcare
  • Industrials
  • Information Technology
  • Materials
  • Real Estate
  • Telecommunication Services
  • Uncategorised
  • Utilities
  • Publishing Policy
  • About Us
  • Author Biography
The Capital Club